Comparison · NCT03440814-sae
DCCR vs Placebo for DCCR: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. DCCR vs Placebo for DCCR: serious adverse events. Trial comparisons, record NCT03440814-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03440814-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0714 | 0.0331 | 0.147 | wilson | |
| Risk in group 2 | 0 | 0 | 0.0838 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0714 | -0.0207 | 0.147 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | log | a group has no participants with the outcome | |||
| Odds ratio, group 1 over group 2 | log | a cell of the two-by-two table is zero | |||
| Number needed to harm, for one more participant with a serious adverse event on DCCR than on Placebo for DCCR | 14 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | DCCR | Participants with PWS were dosed dependent on their weight; 25mg, 75mg or 150mg DCCR tablets could be taken; DCCR was taken daily. Tablets must be swallowed whole and should not be broken, crushed or chewed.~The target dose by weight (kg) was as follows:~Subjects weighing 20 to \< 30 kg took 100mg DCCR/day; Subjects weighing ≥ 30 to \< 40 took 150mg DCCR/day; Subjects weighing ≥ 40 to \< 65 took 225mg DCCR/day; Subjects weighing ≥ 65 to \< 100 took 375mg DCCR/day; Subjects weighing ≥ 100 to \< 135 took 450mg DCCR/day. Subjects randomized to the DCCR treatment group were titrated every 2 weeks until the target dose was achieved. | 6 | 84 | EG000 |
| Group 2 | Placebo for DCCR | Participants with PWS were dosed dependent on their weight; 25mg, 75mg or 150mg placebo for DCCR tablets could be taken; Placebo was taken daily. Tablets must be swallowed whole and should not be broken, crushed or chewed.~The target dose by weight (kg) was as follows:~Subjects weighing 20 to \< 30 kg took 100mg DCCR/day; Subjects weighing ≥ 30 to \< 40 took 150mg DCCR/day; Subjects weighing ≥ 40 to \< 65 took 225mg DCCR/day; Subjects weighing ≥ 65 to \< 100 took 375mg DCCR/day; Subjects weighing ≥ 100 to \< 135 took 450mg DCCR/day. Subjects randomized to the Placebo group were titrated on placebo, similar to the DCCR group. | 0 | 42 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
- Baseline to Visit 7 (Week 13)
Source ClinicalTrials.gov
Trial
- Title
- A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
- NCT number
- NCT03440814
- Phases
- PHASE3
- Conditions
- Prader-Willi Syndrome
- Interventions
- DCCR, Placebo for DCCR
- Lead sponsor
- Soleno Therapeutics, Inc.
- Results first posted
- 2023-09-21
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03440814?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03440814-sae